1. Home
  2. Author
  3. Krassnigg A

Krassnigg A

References (2)

Title : Identification and validation of fusidic acid and flufenamic acid as inhibitors of SARS-CoV-2 replication using DrugSolver CavitomiX - Hetmann_2023_Sci.Rep_13_11783
Author(s) : Hetmann M , Langner C , Durmaz V , Cespugli M , Kochl K , Krassnigg A , Blaschitz K , Groiss S , Loibner M , Ruau D , Zatloukal K , Gruber K , Steinkellner G , Gruber CC
Ref : Sci Rep , 13 :11783 , 2023
Abstract : Hetmann_2023_Sci.Rep_13_11783
ESTHER : Hetmann_2023_Sci.Rep_13_11783
PubMedSearch : Hetmann_2023_Sci.Rep_13_11783
PubMedID: 37479788

Title : On the prodrug potential of novel aldose reductase inhibitors with diphenylmethyleneaminooxycarboxylic acid structure - Rakowitz_2002_Eur.J.Pharm.Sci_15_11
Author(s) : Rakowitz D , Matuszczak B , Gritsch S , Hofbauer P , Krassnigg A , Costantino L
Ref : Eur J Pharm Sci , 15 :11 , 2002
Abstract : Rakowitz_2002_Eur.J.Pharm.Sci_15_11
ESTHER : Rakowitz_2002_Eur.J.Pharm.Sci_15_11
PubMedSearch : Rakowitz_2002_Eur.J.Pharm.Sci_15_11
PubMedID: 11803127